Log in
Enquire now
‌

US Patent 7842676 Fixed ratio drug combination treatments for solid tumors

Patent 7842676 was granted and assigned to Celator Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of irinotecan and floxuridine. Such methods are particularly useful in the treatment of cancer patients with advanced solid tumors.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7842676 Fixed ratio drug combination treatments for solid tumors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.